scholarly article | Q13442814 |
P356 | DOI | 10.1136/HEARTJNL-2014-305583 |
P698 | PubMed publication ID | 24968886 |
P50 | author | Raphael Twerenbold | Q30537260 |
Karin Wildi | Q45394445 | ||
Maria Rubini Giménez | Q50727213 | ||
Tobias Reichlin | Q87867254 | ||
Petra Hillinger | Q87879529 | ||
Christian Puelacher | Q89562887 | ||
Ursina Honegger | Q89838301 | ||
Kris Denhaerynck | Q96684268 | ||
Stefan Osswald | Q100508869 | ||
Philip Haaf | Q114330460 | ||
Berit Moehring | Q117271223 | ||
Milos Radosavac | Q117271226 | ||
Zoraida Moreno Weidmann | Q117271227 | ||
Cedric Jaeger | Q117271230 | ||
Carmela Schumacher | Q117271233 | ||
Christiane Arnold | Q117271234 | ||
Philipp Kreutzinger | Q117271237 | ||
Fabio Stallone | Q117271239 | ||
P2093 | author name string | Roland Bingisser | |
Christian Mueller | |||
Jörn Ole Vollert | |||
Nicole Fuechslin | |||
P2860 | cites work | Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction | Q22242900 |
A Systematic Review and Collaborative Meta-Analysis to Determine the Incremental Value of Copeptin for Rapid Rule-Out of Acute Myocardial Infarction | Q22252541 | ||
Direct hospital costs of chest pain patients attending the emergency department: a retrospective study | Q33242296 | ||
Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain | Q33906876 | ||
C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study | Q34003454 | ||
Incremental value of copeptin for rapid rule out of acute myocardial infarction | Q34018239 | ||
Copeptin improves early diagnosis of acute myocardial infarction | Q34113939 | ||
Missed diagnoses of acute cardiac ischemia in the emergency department. | Q34508319 | ||
Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study | Q35059506 | ||
Copeptin and risk stratification in patients with acute dyspnea | Q35561316 | ||
Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. | Q37599608 | ||
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study | Q38487799 | ||
Early diagnosis of myocardial infarction with sensitive cardiac troponin assays | Q43285257 | ||
Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections | Q44180412 | ||
Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain | Q44325501 | ||
Short-term mortality risk in emergency department acute heart failure | Q46176110 | ||
Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients | Q46515718 | ||
Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure | Q48252671 | ||
Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. | Q50634259 | ||
Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. | Q53081382 | ||
Copeptin and Peroxiredoxin-4 Independently Predict Mortality in Patients With Nonspecific Complaints Presenting to the Emergency Department | Q57759242 | ||
Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD | Q57759362 | ||
How to use high-sensitivity cardiac troponins in acute cardiac care | Q58314226 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1708-1714 | |
P577 | publication date | 2014-06-26 | |
P1433 | published in | Heart | Q856338 |
P1476 | title | Prevalence, characteristics and outcome of non-cardiac chest pain and elevated copeptin levels | |
P478 | volume | 100 |
Q38714574 | Almanac 2015: coronary artery disease |
Q48351553 | Clinical features and prognosis of patients with acute non-specific chest pain in emergency and cardiology departments after the introduction of high-sensitivity troponins: a prospective cohort study |
Q35556651 | Copeptin testing in acute myocardial infarction: ready for routine use? |
Q89057826 | Non-Cardiac Chest Pain |
Q39185614 | Prognostic Biomarkers in Acute Coronary Syndromes: Risk Stratification Beyond Cardiac Troponins |
Q38424879 | The head says yes but the heart says no: what is non-cardiac chest pain and how is it managed? |
Q38631843 | The prevalence of non-cardiac chest pain (NCCP) using emergency department (ED) data: a Northern Ireland based study |
Q64113138 | Unrecognized esophageal fish bone impaction with delayed presentation of acute spastic central chest pain: A case report |
Search more.